Greg Keenan - 07 Nov 2024 Form 3 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Chief Medical Officer
Signature: /s/ Greg Keenan, M.D.
Issuer symbol: AUPH
Transactions as of: 07 Nov 2024
Net transactions value: $0
Form type: 3
Filing time: 12 Nov 2024, 19:05:46 UTC
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AUPH	Common Stock						111,445	07 Nov 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AUPH	Stock Option (right to buy)							07 Nov 2024	Common Stock	81,990	$8.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents two grants of Restricted Stock Units (RSUs) granted on March 6, 2023 and January 30, 2024, both payable solely in common stock of the Issuer. The RSUs vest in three (3) equal annual installments on the first, second and third anniversary of the grant dates.
F2	One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.